CoChat

Direct Comparison of the Diagnostic Capability of Cardiac Magnetic Resonance and Endomyocardial Biopsy in Patients with Heart Failure

Open access
Yoshida, Akemi, Ishibashi-Ueda, Hatsue, Yamada, Naoaki, Kanzaki, Hideaki, Hasegawa, Takuya, Takahama, Hiroyuki, Amaki, Makoto, Asakura, Masanori, Kitakaze, Masafumi · 2013 · European Journal of Heart Failure
Cited by 81

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Aims: The diagnostic performance of cardiac magnetic resonance (CMR) has not been compared with that of other imaging modalities. Therefore, this study investigated the diagnostic capabilities of CMR and endomyocardial biopsy (EMB) in patients with heart failure (HF). Methods and results: We studied 136 patients with cardiomyopathy who underwent both CMR and EMB. Independent diagnoses were made according to the results of (i) CMR alone; (ii) EMB alone; (iii) clinical data plus echocardiogram; (iv) clinical data, echocardiogram, plus CMR; and (v) clinical data, echocardiogram, plus EMB. These diagnoses were then compared with the final diagnosis (gold standard) that was made using the complete clinical data, including EMB and CMR. The sensitivities of the diagnosis strategies of (i–v) relative to the final diagnosis were 67, 79, 86, 97, and 100%, respectively. CMR alone demonstrated better sensitivity for cardiac sarcoidosis and greater specificity for dilated cardiomyopathy than EMB alone. CMR also tended to show better sensitivity for hypertensive heart disease. There was no difference between the diagnostic capability of CMR and EMB for hypertrophic cardiomyopathy (HCM). However, CMR showed excellent sensitivity (100%) for apical and obstructive HCM, whereas EMB displayed better sensitivity for dilated HCM. Moreover, combined diagnosis with clinical data, echocardiogram, plus CMR achieved superior agreement with the final diagnosis in comparison with EMB alone. Conclusion: Non-invasive CMR demonstrated excellent diagnostic capability for patients with HF and was as effective as or superior to EMB. In particular, the use of CMR in combination with clinical data unrelated to EMB may provide excellent diagnostic accuracy for HF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjhf/hfs206

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 81

Metadata

Authors
Yoshida, A., Ishibashi-Ueda, H., Yamada, N., Kanzaki, H., Hasegawa, T., Takahama, H., Amaki, M., Asakura, M., & Kitakaze, M.
Venue
European Journal of Heart Failure
Published
2013-02-01
Volume
15
Issue
2
Pages
166-175
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2048603478
Cited by
81
References
1
FWCI
6.36
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Direct Comparison of the Diagnostic Capability of Cardiac Magnetic Resonance and Endomyocardial Biopsy in Patients with Heart Failure. https://app.cochat.ai/papers/10.1093/eurjhf/hfs206
The paper
Yoshida, A., Ishibashi-Ueda, H., Yamada, N., Kanzaki, H., Hasegawa, T., Takahama, H., Amaki, M., Asakura, M., & Kitakaze, M. (2013). Direct Comparison of the Diagnostic Capability of Cardiac Magnetic Resonance and Endomyocardial Biopsy in Patients with Heart Failure. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hfs206

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.